NASDAQ:AKBA | Operating Income | Akebia Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$6.33M
2026-03-31-$4.7M
2025-12-31-$8.55M
2025-09-30$4.45M
2025-06-30$14.09M
2025-03-31$13.51M
2024-12-31-$14.31M
2024-09-30-$12.51M
2024-06-30-$8.73M
2024-03-31-$14.94M
2023-12-31$1.37M
2023-09-30-$13.04M
2023-06-30-$9M
2023-03-31-$25.6M
2022-12-31-$4.87M
2022-09-30-$50.41M
2022-06-30$34.08M
2022-03-31-$59.58M
2021-12-31-$66.16M
2021-09-30-$54.89M
2021-06-30-$79.34M
2021-03-31-$64.94M
2020-12-31-$85.4M
2020-09-30-$58.1M
2020-06-30-$173.82M
2020-03-31-$59.13M
2019-12-31-$94.89M
2019-09-30-$55.91M
2019-06-30-$59.52M
2019-03-31-$75.97M
2018-12-31-$90.16M
2018-09-30-$27.84M
2018-06-30-$35.66M
2018-03-31-$24.5M
2017-12-31$14.61M
2017-09-30-$24.18M
2017-06-30-$22.14M
2017-03-31-$44.97M
2016-12-31-$38.04M
2016-09-30-$36.18M
2016-06-30-$36.19M
2016-03-31-$26.05M
2015-12-31-$20.05M
2015-09-30-$19.68M
2015-06-30-$10.89M
2015-03-31-$10.9M
2014-12-31-$10.61M
2014-09-30-$9.58M
2014-06-30-$7.84M
2014-03-31-$9.91M
2013-12-31-$6.2M
2013-09-30-$4.03M
2013-06-30-$3.12M
2013-03-31-$2.58M

Annual Operating Income

DateOperating Income
2025-12-31$23.5M
2024-12-31-$50.47M
2023-12-31-$46.26M
2022-12-31-$80.78M
2021-12-31-$265.32M
2020-12-31-$376.44M
2019-12-31-$286.29M
2018-12-31-$178.16M
2017-12-31-$76.67M
2016-12-31-$136.46M
2015-12-31-$61.51M
2014-12-31-$37.94M
2013-12-31-$15.93M
2012-12-31-$8.52M